读两篇肝细胞癌合并门静脉癌栓专家共识有感

Comments on the Expert Consensus of Cantonese and Eeastern Hepatobiliary Surgical Hospitals on hepatocellular carcinoma with portal vein tumor thrombus

门静脉癌栓（PVTT）是肝细胞癌（HCC）患者常见的肿瘤晚期征象，预后差。HCC伴PVTT是临床治疗的难点，虽然治疗方法众多，但疗效均不理想。目前，国内外尚无针对HCC伴PVTT的治疗指南。近期国内连续发表两篇关于HCC伴PVTT治疗的专家共识。本文对这两篇共识进行了对比分析，以便临床医生更好地掌握和理解HCC伴PVTT的治疗共识。

Hepatocellular carcinoma with portal vein tumor thrombus （PVTT） , an advanced stage of disease, is com- mon. Patients who have hepatocellular carcinoma （HCC） with PVTt have a poor outcome. The management of HCC with PVTt is a clinical challenge. Although many treatment options are available, there are currently no consensus or guideline on opti- mal management of HCC with PVTT. To improve understanding of the two guidelines published recently, we compared the simi- larities and differences between them.